Literature DB >> 15589315

The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity.

Hitomi Sano1, Yoshio Kuroki.   

Abstract

Pulmonary surfactant, which covers the peripheral airway, is a mixture of lipids and proteins. The hydrophilic surfactant proteins A (SP-A) and D (SP-D) play important roles in host defense mechanisms of the lung. These proteins belong to a collectin subgroup in which lectin domains are associated with collagenous structures. Collectins involve mannose-binding lectin, and are considered to function in innate immune systems. SP-A and SP-D interact with various microorganisms and pathogen-derived components. They act as opsonins by binding and agglutinating pathogens. The lung collectins also possess direct inhibitory effects on bacterial growth. SP-A and SP-D associate with immune cells, and activate various cellular functions. The direct interactions of SP-A and SP-D with macrophages result in modulation of phagocytosis or the production of reactive oxygen species. Moreover, by associating with cell surface pattern-recognition receptors, SP-A and SP-D regulate inflammatory cellular responses such as the release of lipopolysaccharides-induced proinflammatory cytokines. Animal models of SP-A- or SP-D-deficiency reveal significant defect in host defense. Significant susceptibility to bacterial and viral infections, delayed microbial clearance, and overexpression of proinflammatory cytokines are observed in SP-A or SP-D knockout mice. A more complete understanding of the mechanisms is required, but the biological relevance of SP-A and SP-D against various respiratory infections has been increasingly recognized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15589315     DOI: 10.1016/j.molimm.2004.07.014

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  63 in total

1.  Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4.

Authors:  Agnieszka J Connor; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2012-01-24       Impact factor: 3.362

2.  C1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury.

Authors:  Dilip Shah; Freddy Romero; Ying Zhu; Michelle Duong; Jianxin Sun; Kenneth Walsh; Ross Summer
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

3.  Pneumocytes Assemble Lung Surfactant as Highly Packed/Dehydrated States with Optimal Surface Activity.

Authors:  Alejandro Cerrada; Thomas Haller; Antonio Cruz; Jesús Pérez-Gil
Journal:  Biophys J       Date:  2015-12-01       Impact factor: 4.033

4.  Surfactant protein D inhibits lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human renal tubular epithelial cells: implication for tubulointerstitial fibrosis.

Authors:  F Hu; W Liang; Z Ren; G Wang; G Ding
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

5.  Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.

Authors:  Hany Sahly; Yona Keisari; Erika Crouch; Nathan Sharon; Itzhak Ofek
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

6.  Surfactant protein A stimulates release of neutrophil chemotactic factors by alveolar type II pneumocytes.

Authors:  Mitchell J Kresch; Mitchell Block; Mohammed R Karim; Li Zhu; Naveed Hussain; Roger S Thrall; Ramadan I Sha'afi
Journal:  Lung       Date:  2010-05-16       Impact factor: 2.584

7.  Crystallographic complexes of surfactant protein A and carbohydrates reveal ligand-induced conformational change.

Authors:  Feifei Shang; Michael J Rynkiewicz; Francis X McCormack; Huixing Wu; Tanya M Cafarella; James F Head; Barbara A Seaton
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

8.  Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.

Authors:  Koji Kuronuma; Hiroaki Mitsuzawa; Katsuyuki Takeda; Chiaki Nishitani; Edward D Chan; Yoshio Kuroki; Mari Nakamura; Dennis R Voelker
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

9.  Lung infections and innate host defense.

Authors:  Ma Valdivia-Arenas; A Amer; Ln Henning; Md Wewers; Ls Schlesinger
Journal:  Drug Discov Today Dis Mech       Date:  2007

10.  Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection.

Authors:  Mari Numata; Hong Wei Chu; Azzeddine Dakhama; Dennis R Voelker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.